Literature DB >> 11316806

Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain.

H L Tiffany1, M C Lavigne, Y H Cui, J M Wang, T L Leto, J L Gao, P M Murphy.   

Abstract

Amyloid-beta, the pathologic protein in Alzheimer's disease, induces chemotaxis and production of reactive oxygen species in phagocytic cells, but mechanisms have not been fully defined. Here we provide three lines of evidence that the phagocyte G protein-coupled receptor (N-formylpeptide receptor 2 (FPR2)) mediates these amyloid-beta-dependent functions in phagocytic cells. First, transfection of FPR2, but not related receptors, including the other known N-formylpeptide receptor FPR, reconstituted amyloid-beta-dependent chemotaxis and calcium flux in HEK 293 cells. Second, amyloid-beta induced both calcium flux and chemotaxis in mouse neutrophils (which express endogenous FPR2) with similar potency as in FPR2-transfected HEK 293 cells. This activity could be specifically desensitized in both cell types by preincubation with a specific FPR2 agonist, which desensitizes the receptor, or with pertussis toxin, which uncouples it from G(i)-dependent signaling. Third, specific and reciprocal desensitization of superoxide production was observed when N-formylpeptides and amyloid-beta were used to sequentially stimulate neutrophils from FPR -/- mice, which express FPR2 normally. Potential biological relevance of these results to the neuroinflammation associated with Alzheimer's disease was suggested by two additional findings: first, FPR2 mRNA could be detected by PCR in mouse brain; second, induction of FPR2 expression correlated with induction of calcium flux and chemotaxis by amyloid-beta in the mouse microglial cell line N9. Further, in sequential stimulation experiments with N9 cells, N-formylpeptides and amyloid-beta were able to reciprocally cross-desensitize each other. Amyloid-beta was also a specific agonist at the human counterpart of FPR2, the FPR-like 1 receptor. These results suggest a unified signaling mechanism for linking amyloid-beta to phagocyte chemotaxis and oxidant stress in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316806     DOI: 10.1074/jbc.M101031200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease.

Authors:  Anne Rovelet-Lecrux; Solenn Legallic; David Wallon; Jean-Michel Flaman; Olivier Martinaud; Stéphanie Bombois; Adeline Rollin-Sillaire; Agnès Michon; Isabelle Le Ber; Jérémie Pariente; Michèle Puel; Claire Paquet; Bernard Croisile; Catherine Thomas-Antérion; Martine Vercelletto; Richard Lévy; Thierry Frébourg; Didier Hannequin; Dominique Campion
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

2.  Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry.

Authors:  Kiyoshi Itagaki; Carl J Hauser
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

3.  Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence.

Authors:  Maren Rautenberg; Hwang-Soo Joo; Michael Otto; Andreas Peschel
Journal:  FASEB J       Date:  2010-12-23       Impact factor: 5.191

Review 4.  Expression and signaling of formyl-peptide receptors in the brain.

Authors:  Fabio Cattaneo; Germano Guerra; Rosario Ammendola
Journal:  Neurochem Res       Date:  2010-11-02       Impact factor: 3.996

5.  Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.

Authors:  Susan M Young; Cristian M Bologa; Dan Fara; Bj K Bryant; Juan Jacob Strouse; Jeffrey B Arterburn; Richard D Ye; Tudor I Oprea; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

6.  Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.

Authors:  Ana María Martín-Moreno; David Reigada; Belén G Ramírez; R Mechoulam; Nadia Innamorato; Antonio Cuadrado; María L de Ceballos
Journal:  Mol Pharmacol       Date:  2011-02-24       Impact factor: 4.436

7.  Do amyloid structures formed by Staphylococcus aureus phenol-soluble modulins have a biological function?

Authors:  Yue Zheng; Hwang-Soo Joo; Vinod Nair; Katherine Y Le; Michael Otto
Journal:  Int J Med Microbiol       Date:  2017-09-01       Impact factor: 3.473

Review 8.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

9.  Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections.

Authors:  Elisabeth Weiss; Dennis Hanzelmann; Beate Fehlhaber; Andreas Klos; Friederike D von Loewenich; Jan Liese; Andreas Peschel; Dorothee Kretschmer
Journal:  FASEB J       Date:  2017-08-30       Impact factor: 5.191

Review 10.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.